Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2013 Jan;15(1):267-70.
doi: 10.1093/ntr/ntr316. Epub 2012 Feb 6.

Electronic cigarettes: effective nicotine delivery after acute administration

Affiliations
Clinical Trial

Electronic cigarettes: effective nicotine delivery after acute administration

Andrea Rae Vansickel et al. Nicotine Tob Res. 2013 Jan.

Abstract

Introduction: Electronic cigarettes (ECs) are marketed as nicotine delivery devices. Two studies with EC-naïve participants suggest that ECs deliver little or no nicotine. In those studies, standard-sized ECs were used, though experienced EC users often use larger devices that house higher voltage and/or longer lasting batteries. Whether user experience and device characteristics influence EC nicotine delivery is uncertain. The purpose of the present study was to examine the effects of ECs in experienced users who were using their preferred devices.

Methods: Eight EC users (3 women) who had been using ECs for at least 3 months, completed one 5-hr session using devices they provided and the flavor/strength nicotine cartridges they selected. Sessions consisted of 4 phases: baseline, 10 puffs (30-s interpuff interval) from the device, 1-hr ad lib puffing period, and a 2-hr rest period (no puffing). Outcome measures in each phase included plasma nicotine concentration, heart rate, and subjective ratings of nicotine/product effects and abstinence symptoms.

Results: Relative to baseline, plasma nicotine and heart rate increased significantly within 5 min of the first puff and remained elevated throughout the ad lib puffing period. Increases in ratings of direct effects of nicotine and product were observed as well as decreases in abstinence symptoms.

Conclusions: User experience and/or device characteristics likely influence EC nicotine delivery and other effects. Systematic manipulation of these and other variables could elucidate conditions that produce intended effects.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Top panel: M (±1 SEM) plasma nicotine (assay’s limit of quantitation = 2 ng/ml; Breland, Kleykamp, & Eissenberg, 2006) levels at baseline (−5) and during the 10-puff and 1-hr ad lib puffing periods. Filled symbols indicate a significant difference from baseline. Bottom panel: M (+1 SEM) response to a visual analogue scale item assessing “restlessness” (0–100 scale) at baseline and the end of the 10-puff, ad lib, and rest periods. An asterisk indicates a significant difference from baseline. Data are from eight electronic cigarettes (EC) using participants who abstained from ECs for at least 12 hr before session. Paired t tests were used to compare means, p ≤ .05.

Similar articles

Cited by

References

    1. Ayers JW, Ribisi KM, Brownstein JS. Tracking the rise in popularity of electronic nicotine delivery systems (electronic cigarettes) using search query surveillance. American Journal of Preventive Medicine. 2011;40:448–453. doi:10.1016/j.amepre.2010.12.007. - PubMed
    1. Blank MD, Sams C, Weaver MF, Eissenberg T. Nicotine delivery, cardiovascular profile, and subjective effects of an oral tobacco product for smokers. Nicotine & Tobacco Research. 2008;10:417–421. doi:10.1080/14622200801901880. - PMC - PubMed
    1. Breland AB, Kleykamp BA, Eissenberg T. Clinical laboratory evaluation of potential reduced exposure products for smokers. Nicotine & Tobacco Research. 2006;8:727–738. doi:10.1080/14622200600789585. - PubMed
    1. Bullen C, McRobie H, Thornley S, Glover M, Laugesen M. Effect of an electronic cigarette on desire to smoke and withdrawal, user preferences and nicotine delivery: Randomized cross-over trial. Tobacco Control. 2010;19:98–103. doi:10.1136/tc.2009.031567. - PubMed
    1. Carter LP, Griffiths RR. Principles of laboratory assessment of drug abuse liability and implications for clinical development. Drug and Alcohol Dependence. 2009;105S:14–25. doi:10.1016/j.drugalcdep.2009.04.003. - PMC - PubMed

Publication types